-
World Federation of Neurology Joins Forces with the World Health Organization, Announcing "Groundbreaking" Reclassification of Stroke as a Disorder of the Brain; Launches Nine-Country Survey, Leading to Roadmap for Improved Neurological Care
En-CPhI.CN
October 29, 2019
The World Federation of Neurology (WFN) is joining forces with the World Health Organization (WHO) to create global standards of neurological care.
-
Countries must invest at least 1% more of GDP on primary health care: WHO
biospectrumasia
September 25, 2019
On 23 September, world leaders will discuss a far-reaching Declaration on Universal Health Coverage. The Declaration lists a number of steps to advance progress towards UHC.
-
WHO: 'Dramatic Resurgence' of Measles Occurring in Europe
drugs
August 30, 2019
Vaccine refusals have contributed to a "dramatic resurgence" of measles in Europe, the World Health Organization says.
-
WHO: Malaria Eradication Not Currently Possible
drugs
August 26, 2019
The eradication of malaria worldwide may eventually be possible, but when that might be achieved is unclear, according to the World Health Organization.
-
WHO: Microplastics in Drinking Water Not a Health Risk
drugs
August 23, 2019
Levels of microplastics in drinking water do not appear to be a health risk, according to the World Health Organization.
-
WHO 'Treat All' Recommendation for HIV Widely Implemented
drugs
July 25, 2019
The World Health Organization "Treat All" strategy for antiretroviral treatment (ART) initiation among patients living with HIV was the standard of care at...
-
WHO recommends dolutegravir as preferred HIV treatment option
biospectrumasia
July 23, 2019
Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including pregnant women and those of childbearing potential.
-
Abiraterone Acetate Included in WHO’s Essential Medicines List
americanpharmaceuticalreview
July 22, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the World Health Organization (WHO) will include abiraterone acetate (ZYTIGA®) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medic
-
WHO Declares Congo Ebola Outbreak Global Health Emergency
drugs
July 18, 2019
The World Health Organization on Wednesday called the year-old outbreak of Ebola in the Democratic Republic of Congo a global health emergency...
-
WHO updates global guidance on medicines
biospectrumasia
July 10, 2019
New essential medicines and diagnostics lists published